Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 80 | 2024 | 249 | 17.970 |
Why?
|
| Knee Joint | 52 | 2024 | 162 | 7.350 |
Why?
|
| Osteoarthritis | 11 | 2024 | 89 | 4.250 |
Why?
|
| Disease Progression | 33 | 2024 | 2103 | 2.350 |
Why?
|
| Arthralgia | 9 | 2024 | 56 | 2.170 |
Why?
|
| Tibia | 14 | 2023 | 72 | 2.140 |
Why?
|
| Radiography | 24 | 2024 | 805 | 1.910 |
Why?
|
| Bone Density | 8 | 2018 | 324 | 1.780 |
Why?
|
| Running | 3 | 2018 | 36 | 1.700 |
Why?
|
| Cartilage, Articular | 13 | 2023 | 58 | 1.680 |
Why?
|
| Bone Marrow | 12 | 2020 | 326 | 1.360 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2023 | 3622 | 1.300 |
Why?
|
| Pain | 10 | 2024 | 453 | 1.220 |
Why?
|
| Middle Aged | 68 | 2024 | 27031 | 1.120 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 1341 | 1.120 |
Why?
|
| Aged | 57 | 2024 | 19962 | 1.100 |
Why?
|
| Knee Injuries | 9 | 2023 | 39 | 1.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 7 | 2023 | 136 | 1.040 |
Why?
|
| Synovitis | 7 | 2022 | 25 | 0.950 |
Why?
|
| Pain Measurement | 13 | 2019 | 345 | 0.940 |
Why?
|
| Cross-Sectional Studies | 16 | 2024 | 3457 | 0.890 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.870 |
Why?
|
| Exercise Therapy | 2 | 2024 | 162 | 0.870 |
Why?
|
| Weight-Bearing | 7 | 2016 | 43 | 0.860 |
Why?
|
| Resistance Training | 1 | 2023 | 32 | 0.850 |
Why?
|
| Walking | 5 | 2022 | 218 | 0.850 |
Why?
|
| Menisci, Tibial | 7 | 2023 | 37 | 0.840 |
Why?
|
| Exercise | 6 | 2024 | 828 | 0.800 |
Why?
|
| Humans | 98 | 2024 | 126330 | 0.780 |
Why?
|
| Methotrexate | 1 | 2024 | 336 | 0.770 |
Why?
|
| Femur | 6 | 2023 | 68 | 0.770 |
Why?
|
| Male | 72 | 2024 | 62031 | 0.760 |
Why?
|
| Female | 74 | 2024 | 67333 | 0.690 |
Why?
|
| Swimming | 1 | 2019 | 22 | 0.660 |
Why?
|
| Football | 1 | 2020 | 32 | 0.660 |
Why?
|
| Chronic Pain | 1 | 2021 | 124 | 0.630 |
Why?
|
| Tibial Meniscus Injuries | 4 | 2019 | 29 | 0.620 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 2933 | 0.590 |
Why?
|
| Cancellous Bone | 1 | 2018 | 7 | 0.580 |
Why?
|
| Physicians | 1 | 2024 | 603 | 0.550 |
Why?
|
| Bone Malalignment | 2 | 2016 | 4 | 0.530 |
Why?
|
| Knee | 2 | 2015 | 17 | 0.520 |
Why?
|
| Osteoarthritis, Hip | 3 | 2023 | 54 | 0.500 |
Why?
|
| Absorptiometry, Photon | 6 | 2018 | 181 | 0.490 |
Why?
|
| Risk Factors | 23 | 2023 | 10375 | 0.490 |
Why?
|
| Bone Marrow Diseases | 3 | 2011 | 41 | 0.470 |
Why?
|
| Quality of Life | 1 | 2024 | 1954 | 0.460 |
Why?
|
| Motor Activity | 2 | 2015 | 527 | 0.460 |
Why?
|
| Hand Joints | 2 | 2024 | 6 | 0.430 |
Why?
|
| Pain Management | 3 | 2019 | 182 | 0.400 |
Why?
|
| Body Mass Index | 11 | 2020 | 1582 | 0.380 |
Why?
|
| Blood Pressure | 1 | 2017 | 1357 | 0.370 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 13 | 0.360 |
Why?
|
| Analgesics | 2 | 2009 | 127 | 0.350 |
Why?
|
| Logistic Models | 9 | 2017 | 1812 | 0.340 |
Why?
|
| Cohort Studies | 8 | 2024 | 4874 | 0.310 |
Why?
|
| Joint Instability | 2 | 2019 | 44 | 0.310 |
Why?
|
| Hypertension | 1 | 2017 | 1296 | 0.300 |
Why?
|
| Prospective Studies | 6 | 2023 | 6175 | 0.290 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 3716 | 0.280 |
Why?
|
| United States | 9 | 2020 | 10990 | 0.270 |
Why?
|
| Symptom Assessment | 2 | 2018 | 101 | 0.260 |
Why?
|
| Time Factors | 10 | 2019 | 6334 | 0.260 |
Why?
|
| Vasculitis | 1 | 2006 | 49 | 0.260 |
Why?
|
| Biomechanical Phenomena | 3 | 2017 | 244 | 0.250 |
Why?
|
| Incidence | 6 | 2022 | 3170 | 0.240 |
Why?
|
| Life Style | 1 | 2008 | 423 | 0.240 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 443 | 0.240 |
Why?
|
| Retrospective Studies | 7 | 2024 | 16517 | 0.240 |
Why?
|
| Case-Control Studies | 10 | 2023 | 3341 | 0.230 |
Why?
|
| Denmark | 1 | 2024 | 27 | 0.230 |
Why?
|
| Gardening | 1 | 2024 | 10 | 0.220 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 240 | 0.220 |
Why?
|
| Skin | 1 | 2006 | 527 | 0.210 |
Why?
|
| Prognosis | 6 | 2023 | 4742 | 0.210 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 103 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2019 | 3461 | 0.200 |
Why?
|
| Walking Speed | 2 | 2020 | 17 | 0.200 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 367 | 0.200 |
Why?
|
| Carpometacarpal Joints | 1 | 2022 | 2 | 0.200 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 125 | 0.190 |
Why?
|
| Chiroptera | 1 | 2022 | 13 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 194 | 0.180 |
Why?
|
| Adult | 10 | 2024 | 29802 | 0.180 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2019 | 10 | 0.180 |
Why?
|
| Linear Models | 3 | 2018 | 694 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 236 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2024 | 471 | 0.180 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 2900 | 0.170 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ligaments, Articular | 1 | 2019 | 21 | 0.160 |
Why?
|
| Synovial Membrane | 1 | 2019 | 27 | 0.160 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 5204 | 0.160 |
Why?
|
| Arthrography | 1 | 2018 | 5 | 0.150 |
Why?
|
| Rheumatology | 1 | 2020 | 126 | 0.150 |
Why?
|
| X-Rays | 1 | 2018 | 27 | 0.150 |
Why?
|
| Sound | 1 | 2017 | 22 | 0.140 |
Why?
|
| Iodine | 1 | 2017 | 22 | 0.140 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 42 | 0.140 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2017 | 3 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2019 | 370 | 0.140 |
Why?
|
| Prevalence | 2 | 2022 | 2484 | 0.130 |
Why?
|
| Systole | 1 | 2017 | 201 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 171 | 0.130 |
Why?
|
| Meniscus | 1 | 2016 | 1 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 417 | 0.130 |
Why?
|
| Homeostasis | 2 | 2018 | 710 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 13 | 0.130 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2007 | 38 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 470 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 14 | 0.120 |
Why?
|
| Mammography | 1 | 2016 | 116 | 0.120 |
Why?
|
| Vitamin D | 2 | 2014 | 167 | 0.120 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 167 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 390 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2020 | 1266 | 0.110 |
Why?
|
| Contrast Media | 1 | 2017 | 484 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 73 | 0.110 |
Why?
|
| Age Factors | 5 | 2020 | 2835 | 0.110 |
Why?
|
| Glucose | 1 | 2018 | 881 | 0.100 |
Why?
|
| Cartilage | 1 | 2013 | 48 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 980 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 368 | 0.100 |
Why?
|
| Hand | 2 | 2024 | 101 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2015 | 183 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 1142 | 0.100 |
Why?
|
| Phenotype | 1 | 2022 | 4323 | 0.100 |
Why?
|
| Vitamins | 1 | 2013 | 109 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2106 | 0.090 |
Why?
|
| Hyaline Cartilage | 1 | 2011 | 2 | 0.090 |
Why?
|
| Body Weight | 1 | 2016 | 1004 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2011 | 25 | 0.090 |
Why?
|
| Algorithms | 1 | 2017 | 1647 | 0.080 |
Why?
|
| Young Adult | 2 | 2024 | 9174 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2020 | 12380 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2017 | 1334 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 53 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 51 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 69 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Weight Loss | 1 | 2012 | 491 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1129 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2007 | 43 | 0.070 |
Why?
|
| Arterioles | 1 | 2006 | 28 | 0.070 |
Why?
|
| Cefazolin | 1 | 2006 | 18 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2023 | 214 | 0.070 |
Why?
|
| Osteosclerosis | 1 | 2006 | 12 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 176 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2008 | 1204 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 635 | 0.060 |
Why?
|
| Self Report | 2 | 2020 | 513 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1251 | 0.060 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 26 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2542 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2016 | 74 | 0.050 |
Why?
|
| Child | 2 | 2022 | 24766 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 295 | 0.050 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2022 | 8 | 0.050 |
Why?
|
| Counseling | 1 | 2024 | 223 | 0.050 |
Why?
|
| Thumb | 1 | 2022 | 28 | 0.050 |
Why?
|
| Observer Variation | 2 | 2014 | 299 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1274 | 0.050 |
Why?
|
| Adolescent | 1 | 2019 | 19548 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6645 | 0.050 |
Why?
|
| Diet | 1 | 2008 | 1150 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2022 | 179 | 0.040 |
Why?
|
| London | 1 | 2020 | 12 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2276 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2194 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2024 | 550 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 655 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 145 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1111 | 0.040 |
Why?
|
| Accelerometry | 1 | 2019 | 61 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 722 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 513 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 769 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 256 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 442 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 188 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 858 | 0.040 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2017 | 9 | 0.040 |
Why?
|
| Hong Kong | 1 | 2016 | 13 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1611 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 477 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2406 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 198 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 577 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 71 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2068 | 0.030 |
Why?
|
| Cadaver | 1 | 2014 | 131 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 379 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 444 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 225 | 0.030 |
Why?
|
| Anxiety | 1 | 2019 | 949 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 771 | 0.020 |
Why?
|
| Osteophyte | 1 | 2011 | 7 | 0.020 |
Why?
|
| Prothrombin | 1 | 1991 | 26 | 0.020 |
Why?
|
| Ligaments | 1 | 2011 | 19 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2011 | 25 | 0.020 |
Why?
|
| Tendons | 1 | 2011 | 40 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 110 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1991 | 152 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1245 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1462 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 1758 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 588 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 474 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 784 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1193 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 1722 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1991 | 1559 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1991 | 949 | 0.010 |
Why?
|
| Biomarkers | 1 | 1991 | 3153 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 34533 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3203 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 5965 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1991 | 133 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1991 | 163 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1991 | 943 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1991 | 877 | 0.000 |
Why?
|